Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection

被引:158
作者
Hsue, PY
Giri, K
Erickson, S
MacGregor, JS
Younes, N
Shergill, A
Waters, DD
机构
[1] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
关键词
risk factors; restenosis; coronary disease; angina; infection;
D O I
10.1161/01.CIR.0000114520.38748.AA
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Patients with HIV infection exhibit increased rates of coronary events; however, the clinical features of acute coronary syndromes (ACS) in HIV- infected patients have not been well defined. Methods and Results - Between 1993 and 2003, 68 HIV- infected patients were hospitalized with ACS. We compared the clinical features and outcome of these patients with those of 68 randomly selected control patients with ACS without HIV. HIV patients were on average more than a decade younger than controls and more likely to be male and current smokers and to have low HDL cholesterol. They were less likely than controls to have diabetes or hyperlipidemia, and their TIMI ( Thrombolysis In Myocardial Infarction) risk scores on admission were significantly lower. At coronary angiography, the number of vessels with > 50% stenosis was 1.3 +/- 1.0 in HIV patients and 1.9 +/- 1.2 in controls ( P = 0.007). Restenosis developed in 15 of 29 HIV patients who underwent percutaneous coronary intervention compared with 3 of 21 controls (52% versus 14%, P = 0.006). Conclusions - HIV patients with ACS are younger and more likely to be males and current smokers and to have low HDL cholesterol levels compared with other ACS patients. Their TIMI risk scores are lower, and they are more likely to have single-vessel disease; however, their restenosis rates after percutaneous coronary intervention are unexpectedly high.
引用
收藏
页码:316 / 319
页数:4
相关论文
共 15 条
[1]   Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection [J].
Ambrose, JA ;
Gould, RB ;
Kurian, DC ;
DeVoe, MC ;
Pearlstein, NB ;
Coppola, JT ;
Siegal, FP .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (03) :301-303
[2]   The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making [J].
Antman, EM ;
Cohen, M ;
Bernink, PJLM ;
McCabe, CH ;
Horacek, T ;
Papuchis, G ;
Mautner, B ;
Corbalan, R ;
Radley, D ;
Braunwald, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07) :835-842
[3]   Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection [J].
Bozzette, SA ;
Ake, CF ;
Tam, HK ;
Chang, SW ;
Louis, TA .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (08) :702-710
[4]   Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].
Carr, A ;
Samaras, K ;
Thorisdottir, A ;
Kaufmann, GR ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1999, 353 (9170) :2093-2099
[5]   Combination antiretroviral therapy and the risk of myocardial infarction [J].
Friis-Moller, N ;
Sabin, CA ;
Weber, R ;
Monforte, AD ;
El-Sadr, WM ;
Reiss, P ;
Thiébaut, R ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Lundgren, JD ;
Lundgren, JD ;
Weber, R ;
Monteforte, AD ;
Bartsch, G ;
Reiss, P ;
Dabis, F ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Houyez, F ;
Loeliger, E ;
Tressler, R ;
Weller, I ;
Friis-Moller, N ;
Sabin, CA ;
Sjol, A ;
Lundgren, JD ;
Sawitz, A ;
Rickenbach, M ;
Pezzotti, P ;
Krum, E ;
Meester, R ;
Lavignolle, V ;
Sundström, A ;
Poll, B ;
Fontas, E ;
Torres, F ;
Petoumenos, K ;
Kjær, J ;
Hammer, S ;
Neaton, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :1993-2003
[6]   Severe premature coronary artery disease with protease inhibitors [J].
Henry, K ;
Melroe, H ;
Huebsch, J ;
Hermundson, J ;
Levine, C ;
Swensen, L ;
Daley, J .
LANCET, 1998, 351 (9112) :1328-1328
[7]   Protease inhibitors and cardiovascular outcomes in patients with HIV-1 [J].
Holmberg, SD ;
Moorman, AC ;
Williamson, JM ;
Tong, TC ;
Ward, DJ ;
Wood, KC ;
Greenberg, AE ;
Janssen, RS .
LANCET, 2002, 360 (9347) :1747-1748
[8]  
Hsue P, 2003, CIRCULATION, V108, P633
[9]   T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy [J].
Hunt, PW ;
Martin, JN ;
Sinclair, E ;
Bredt, B ;
Hagos, E ;
Lampiris, H ;
Deeks, SG .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (10) :1534-1543
[10]  
Kokolis S, 2002, CIRCULATION, V106, P392